Standard BioTools IncNASDAQ:LAB
- LAST PRICE1.8150
- TODAY'S CHANGE (%)-0.0450 (-2.4194%)
- Bid / Lots1.8100/ 33
- Ask / Lots1.8200/ 22
- Open / Previous Close1.8300 / 1.8600
- Day Range
- 52 Week Range
- Volume176,873
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | LAB |
|---|---|---|
| 09:32 ET | 5090 | 1.81 |
| 09:34 ET | 16949 | 1.8 |
| 09:36 ET | 7932 | 1.8377 |
| 09:38 ET | 284 | 1.83 |
| 09:39 ET | 600 | 1.8499 |
| 09:41 ET | 295 | 1.8451 |
| 09:45 ET | 875 | 1.83 |
| 09:48 ET | 2319 | 1.83 |
| 09:50 ET | 1161 | 1.825 |
| 09:52 ET | 100 | 1.82 |
| 09:54 ET | 500 | 1.82 |
| 09:59 ET | 200 | 1.83 |
| 10:01 ET | 200 | 1.84 |
| 10:03 ET | 340 | 1.84 |
| 10:06 ET | 3333 | 1.84 |
| 10:08 ET | 1198 | 1.85 |
| 10:10 ET | 825 | 1.845 |
| 10:12 ET | 720 | 1.845 |
| 10:15 ET | 1460 | 1.82 |
| 10:17 ET | 917 | 1.83 |
| 10:19 ET | 1100 | 1.835 |
| 10:21 ET | 100 | 1.83 |
| 10:24 ET | 2156 | 1.83 |
| 10:26 ET | 133 | 1.825 |
| 10:28 ET | 100 | 1.83 |
| 10:30 ET | 203 | 1.82 |
| 10:32 ET | 1434 | 1.825 |
| 10:39 ET | 172 | 1.825 |
| 10:42 ET | 357 | 1.82 |
| 10:44 ET | 4522 | 1.815 |
| 10:46 ET | 500 | 1.814 |
| 10:48 ET | 2032 | 1.825 |
| 10:50 ET | 100 | 1.825 |
| 10:51 ET | 300 | 1.825 |
| 10:53 ET | 102 | 1.825 |
| 10:57 ET | 305 | 1.83 |
| 11:04 ET | 100 | 1.825 |
| 11:08 ET | 100 | 1.83 |
| 11:11 ET | 100 | 1.825 |
| 11:15 ET | 100 | 1.83 |
| 11:18 ET | 731 | 1.83 |
| 11:22 ET | 425 | 1.83 |
| 11:26 ET | 5491 | 1.838 |
| 11:27 ET | 3100 | 1.835 |
| 11:33 ET | 9510 | 1.845 |
| 11:36 ET | 400 | 1.845 |
| 11:38 ET | 174 | 1.845 |
| 11:40 ET | 100 | 1.845 |
| 11:42 ET | 200 | 1.85 |
| 11:44 ET | 1027 | 1.85 |
| 11:45 ET | 3508 | 1.845 |
| 11:49 ET | 239 | 1.845 |
| 11:51 ET | 894 | 1.841258 |
| 11:56 ET | 133 | 1.85 |
| 12:00 ET | 236 | 1.8495 |
| 12:02 ET | 2711 | 1.85 |
| 12:03 ET | 2520 | 1.845 |
| 12:05 ET | 118 | 1.85 |
| 12:09 ET | 5756 | 1.84 |
| 12:12 ET | 100 | 1.845 |
| 12:16 ET | 100 | 1.845 |
| 12:18 ET | 119 | 1.85 |
| 12:20 ET | 100 | 1.85 |
| 12:21 ET | 100 | 1.85 |
| 12:23 ET | 304 | 1.845 |
| 12:30 ET | 324 | 1.85 |
| 12:34 ET | 100 | 1.845 |
| 12:36 ET | 14114 | 1.84 |
| 12:38 ET | 100 | 1.845 |
| 12:39 ET | 115 | 1.85 |
| 12:43 ET | 117 | 1.85 |
| 12:48 ET | 100 | 1.85 |
| 12:50 ET | 200 | 1.845 |
| 12:52 ET | 7601 | 1.835 |
| 12:56 ET | 341 | 1.8307 |
| 12:57 ET | 200 | 1.835 |
| 12:59 ET | 300 | 1.83 |
| 01:01 ET | 2557 | 1.83 |
| 01:03 ET | 100 | 1.8257 |
| 01:06 ET | 661 | 1.83 |
| 01:08 ET | 100 | 1.825 |
| 01:10 ET | 600 | 1.825 |
| 01:15 ET | 318 | 1.825 |
| 01:19 ET | 173 | 1.825 |
| 01:21 ET | 100 | 1.825 |
| 01:24 ET | 400 | 1.83 |
| 01:26 ET | 129 | 1.825 |
| 01:28 ET | 2129 | 1.835 |
| 01:30 ET | 300 | 1.835 |
| 01:32 ET | 9678 | 1.8258 |
| 01:33 ET | 4000 | 1.82 |
| 01:35 ET | 104 | 1.825 |
| 01:37 ET | 320 | 1.824 |
| 01:42 ET | 7190 | 1.815 |
| 01:44 ET | 724 | 1.815 |
Sep 24, 2024
Sep 18, 2024
Standard BioTools proteomics profiling reveals unique biomarkers and insights into nonalcoholic steatohepatitis (NASH), from 8:00AM ET on Wednesday Sep 18, 2024 by Dow Jones
8:00AM ET on Wednesday Sep 18, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Standard BioTools Inc | 690.3M | -2.0x | --- |
Quanterix Corp | 479.7M | -11.6x | --- |
IRadimed Corp | 628.0M | 33.5x | +21.02% |
Simulations Plus Inc | 617.2M | 63.5x | +3.18% |
AxoGen Inc | 619.8M | -34.8x | --- |
Cytek Biosciences Inc | 689.1M | -38.9x | --- |
Company Information
Standard BioTools Inc. develops, manufactures, and sells technologies that help biomedical researchers in their search for developing medicines. The Company's segments include Proteomics and Genomics. The Proteomics segment includes its instruments, consumables, software, and services based upon technologies used in the identification of proteins. The Genomics segment includes its instruments, consumables, software, and services based upon technologies used in the identification of genes and their functions. The Company provides insights in health and disease using its mass cytometry and microfluidics technologies, which serve applications in proteomics and genomic. It works with academic, government, pharmaceutical, biotechnology, plant and animal research, and clinical laboratories around the world, focusing on the needs in translational and clinical research, including oncology, immunology, and immunotherapy. The Company also provides differentiated multi-omics tools for research.
Contact Information
- Headquarters
- 2 Tower Place, Suite 2000SOUTH SAN FRANCISCO, CA, United States 94080
- Phone
- 650-266-6000
- Fax
- 302-655-5049
Executives
- Independent Chairman of the Board
- Tom Carey
- President, Chief Executive Officer, Director
- Michael Egholm
- Interim Chief Financial Officer, Chief Operating Officer
- Hanjoon Kim
- Independent Director
- Eli Casdin
- Independent Director
- Troy Cox
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $690.3M |
|---|---|
Revenue (TTM) | $136.3M |
Shares Outstanding | 371.2M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 1.58 |
EPS | $-0.90 |
Book Value | $2.03 |
P/E Ratio | -2.0x |
Price/Sales (TTM) | 5.1 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -93.94% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
